Northern Trust
JBIO

Northern Trust’s Jade Biosciences JBIO Stock Holding History

Northern Trust’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.4M Sell
241,905
-32,196
-12% -$466K ﹤0.01% 2668
2025
Q4 		$4.23M Buy
274,101
+44,520
+19% +$522K ﹤0.01% 2570
2025
Q3 		$1.98M Buy
229,581
+1,489
+0.7% +$12.2K ﹤0.01% 3043
2025
Q2 		$2.28M Buy
228,092
+224,972
+7,211% +$7.66M ﹤0.01% 2914
2025
Q1 		$274K Buy
3,120
+72
+2% +$6.32K ﹤0.01% 3825
2024
Q4 		$283K Buy
3,048
+180
+6% +$15.5K ﹤0.01% 3869
2024
Q3 		$210K Buy
2,868
+133
+5% +$8.58K ﹤0.01% 3870
2024
Q2 		$159K Sell
2,735
-81
-3% -$53.7K ﹤0.01% 3929
2024
Q1 		$2.91M Sell
2,816
-28
-1% -$21.4K ﹤0.01% 2772
2023
Q4 		$2.25M Sell
2,844
-312
-10% -$159K ﹤0.01% 2932
2023
Q3 		$1.5M Buy
3,156
+642
+26% +$348K ﹤0.01% 3090
2023
Q2 		$1.51M Buy
2,514
+301
+14% +$193K ﹤0.01% 3177
2023
Q1 		$1.56M Sell
2,213
-21
-0.9% -$17.4K ﹤0.01% 3048
2022
Q4 		$2.29M Buy
2,234
+96
+4% +$69.7K ﹤0.01% 2931
2022
Q3 		$1.24M Sell
2,138
-37
-2% -$24.7K ﹤0.01% 3240
2022
Q2 		$1.19M Sell
2,175
-809
-27% -$386K ﹤0.01% 3298
2022
Q1 		$1.92M Buy
2,984
+493
+20% +$191K ﹤0.01% 3125
2021
Q4 		$1.03M Sell
2,491
-29
-1% -$14.7K ﹤0.01% 3533
2021
Q3 		$1.85M Buy
+2,520
New +$1.41M ﹤0.01% 3331

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Northern Trust's JBIO Position: Q1 2026 in Review

Northern Trust reduced its Jade Biosciences (JBIO) stake by 12% in Q1 2026, selling an estimated $466K and leaving 241,905 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

Northern Trust first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.23M in Q4 2025. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Northern Trust held 241,905 shares of Jade Biosciences worth $3.4M as of Q1 2026.
  • Northern Trust sold 32,196 Jade Biosciences shares in Q1 2026, an estimated $466K.
  • Jade Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2668 holding.
  • Northern Trust first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Jade Biosciences position peaked at $4.23M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.